Philippe Donatien Selected Research

Philippe Donatien Research Topics

3	Peripheral Nervous System Diseases (PNS Diseases) 01/2022 - 01/2019
3	Pain (Aches) 01/2022 - 01/2019
2	Neuralgia (Stump Neuralgia) 01/2021 - 01/2019
2	Hypoxia (Hypoxemia) 01/2021 - 11/2016
1	Diabetic Neuropathies (Diabetic Neuropathy) 01/2022
1	Cold Injury 01/2021
1	Type 2 Diabetes Mellitus (MODY) 01/2021
1	Chronic Pain 01/2019
1	Neoplasms (Cancer) 01/2019
1	Cancer Pain 09/2018
1	Arthritis (Polyarthritis) 09/2018
1	Somatoform Disorders (Somatoform Disorder) 09/2018
1	Multiple Sclerosis 09/2018
1	Necrosis 11/2016
1	Synovitis 11/2016
1	Rheumatoid Arthritis 11/2016
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 02/2016
1	Ganglion Cysts (Ganglion) 05/2002
1	Albinism 05/2002

3	Capsaicin (Zostrix)FDA Link 01/2022 - 01/2019
2	NAD (NADH)IBA 01/2022 - 01/2021
1	Biomarkers (Surrogate Marker)IBA 01/2021
1	Nerve Growth Factor (NGF)IBA 01/2021
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 09/2018
1	Etanercept (Enbrel)FDA Link 11/2016
1	Tumor Necrosis Factor InhibitorsIBA 11/2016
1	Oxygen (Dioxygen)IBA 11/2016
1	Infliximab (Remicade)FDA Link 11/2016
1	Complement System Proteins (Complement)IBA 02/2016
1	Retinal Pigments (Pigments, Visual)IBA 05/2002
1	Retinaldehyde (Retinal)IBA 05/2002
1	Monophenol Monooxygenase (Tyrosinase)IBA 05/2002

1	Aftercare (After-Treatment) 01/2021
1	Drug Therapy (Chemotherapy) 01/2019